SPC Logo

Cipralex 5, 10 and 20 mg film-coated tablets

Last Updated on eMC 27-Sep-2013 View document  | Lundbeck Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27-Sep-2013 and displayed until Current

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 21-Sep-2012 and displayed until 27-Sep-2013

Reasons for adding or updating:

  • Change to date of revision
  • Change to information about pregnancy or lactation

Updated on 23-Feb-2012 and displayed until 21-Sep-2012

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions

Updated on 05-Oct-2011 and displayed until 23-Feb-2012

Reasons for adding or updating:

  • Change to packaging

Updated on 21-Feb-2011 and displayed until 05-Oct-2011

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 28-May-2008 and displayed until 21-Feb-2011

Reasons for adding or updating:

  • Transfer to upgraded management system
  • PIL Retired pending re-submission

Updated on 15-Dec-2007 and displayed until 28-May-2008

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
  • Changes to therapeutic indications

Updated on 14-Jun-2002 and displayed until 14-Jun-2002

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Lundbeck Limited

Company image
Address

Lundbeck House, Caldecotte Lake Business Park, Caldecotte, Milton Keynes, MK7 8LG

Fax

+44 (0)1908 647 888

Medical Information e-mail
Telephone

+44 (0)1908 649 966

Medical Information Direct Line

+44 (0)1908 638 972

Customer Care direct line

+44 (0)1908 638 935

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

escitalopram oxalate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.